Company Monitoring Page for Bluebird-Bio

latest headlines for company on cafepharma

Bluebird's not looking to break speed records with its first gene therapy launch
Fierce Pharma
Fri, 05/10/19 - 12:48 pm
Tags:
Bluebird Bio, gene therapy, beta thalassemia, Zynteglo, drug launches
bluebird to rollout Zynteglo starting in Germany next half
BioCentury
Thu, 05/9/19 - 11:09 pm
Tags:
Bluebird Bio, beta thalassemia, Germany, Zynteglo
bluebird bio Flies Forward
Motley Fool
Wed, 05/8/19 - 10:12 am
Tags:
Bluebird Bio, earnings
Celgene reports 'durable' responses to multiple myeloma CAR-T in early trial despite relapses
Fierce Biotech
Fri, 05/3/19 - 10:45 am
Tags:
Celgene, Bluebird Bio, bb2121, cell therapy, CAR-T, Multiple Myeloma
Sanofi leases its soon-to-be-former Genzyme HQ to Bluebird Bio—at a profit
Fierce Pharma
Tue, 04/23/19 - 11:05 pm
Tags:
Sanofi, Bluebird Bio, Kendall Square, Boston
Here's Why Shares of bluebird bio Slumped Today
Motley Fool
Wed, 04/17/19 - 10:36 pm
Tags:
Bluebird Bio
2 Blockbuster Gene Therapy Programs to Watch in 2019
Motley Fool
Sun, 03/31/19 - 03:42 pm
Tags:
gene therapy, Zolgensma, Novartis, Bluebird Bio, LentiGlobin
First gene therapy to treat rare blood disease nears European approval
Stat
Fri, 03/29/19 - 10:05 am
Tags:
Bluebird Bio, Europe, LentiGlobin, gene therapy, beta-thalassemia
Bluebird opens manufacturing facility as it moves gene therapies forward
Fierce Pharma
Tue, 03/26/19 - 11:39 am
Tags:
Bluebird Bio, gene therapy, cell therapy, drug manufacturing
bluebird bio to Cut Ribbon on New Gene Therapy Factory in Durham, NC; Plans to Hire
BioSpace
Fri, 03/22/19 - 10:06 pm
Tags:
Bluebird Bio, gene therapy, drug manufacturing, bb2121, bb21217, LentiGlobin
Here's Why bluebird bio Gained 16.3% in February
Motley Fool
Mon, 03/11/19 - 09:50 am
Tags:
Bluebird Bio
bluebird (BLUE) Q4 Earnings Beat Estimates, Revenues Up Y/Y
Yahoo/Zacks.com
Sat, 02/23/19 - 04:03 pm
Tags:
Bluebird Bio, earnings
[audio+transcript] 6 Biotech Stocks to Watch Now
Motley Fool
Fri, 02/1/19 - 10:36 pm
Tags:
Biogen, Bluebird Bio, Global Blood Therapeutics, Aimmune Therapeutics, Vertex Pharmaceuticals, Sarepta Therapeutics
Where Will bluebird bio Be in 5 Years?
Motley Fool
Thu, 01/24/19 - 11:41 am
Tags:
Bluebird Bio, LentiGlobin, bb21217, CAR-T
Notes from the JPM19 Vortex: Price Apocalypse, Celgene Fallout & More
Xconomy
Fri, 01/11/19 - 09:58 am
Tags:
Celgene, M&A, Juno Therapeutics, Kite Therapeutics, Bluebird Bio, Agios Pharmaceuticals, Jounce Therapeutics, BieGene, Acceleron
bluebird's five-year pricing model for LentiGlobin could resonate with payers
BioCentury
Wed, 01/9/19 - 09:21 am
Tags:
Bluebird Bio, LentiGlobin, Medicaid, drug pricing, payers
Here's Why bluebird bio Shares Got Knocked Down 19.3% in December
Motley Fool
Sat, 01/5/19 - 12:05 am
Tags:
Bluebird Bio, ASH2018, AMG 420, Amgen
Six Things to Watch for at the JP Morgan Healthcare Conference
BioSpace
Fri, 01/4/19 - 10:35 am
Tags:
Moderna Therapeutics, Sarepta Therapeutics, Biogen, Gilead Sciences, Bluebird Bio
15 For ’19: Key Clinical Data To Watch For Next Year (Part 1)
Xconomy
Mon, 12/17/18 - 09:44 am
Tags:
clinical trials, Alzheimer's disease, Biogen, Duchenne Muscular Dystrophy, Pfizer, Solid Biosciences, Sarepta Therapeutics, hemophilia A, Biomarin, Multiple Myeloma, Celgene, Bluebird Bio, Amgen, solid tumors, Bristol-Myers Squibb, Nektar Therapeutics, age-related macular degeneration, Regenxbio, SAGE Therapeutics, MorphoSys
Can Celgene and bluebird bio Survive a Two-Pronged Attack?
Motley Fool
Wed, 12/5/18 - 11:54 am
Tags:
Celgene, Bluebird Bio, bb21217

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.